Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology throughROCK2signalling

Abstract

Most patients with tuberous sclerosis complex (TSC) develop cortical tubers that cause severe neurological disabilities. It has been suggested that defects in neuronal differentiation and/or migration underlie the appearance of tubers. However, the precise molecular alterations remain largely unknown. Here, by combining cytological and immunohistochemical analyses of tubers from nine TSC patients (four of them diagnosed with TSC2 germline mutations), we show that alteration of microtubule biology through ROCK2 signalling contributes to TSC neuropathology. All tubers showed a larger number of binucleated neurons than expected relative to control cortex. An excess of normal and altered cytokinetic figures was also commonly observed. Analysis of centrosomal markers suggested increased microtubule nucleation capacity, which was supported by the analysis of an expression dataset from cortical tubers and control cortex, and subsequently linked to under-expression of Rho-associated coiled-coil containing kinase 2 (ROCK2). Thus, augmented microtubule nucleation capacity was observed in mouse embryonic fibroblasts and human fibroblasts deficient in the Tsc2/TSC2 gene product, tuberin. Consistent with ROCK2 under-expression, microtubule acetylation was found to be increased with tuberin deficiency; this alteration was abrogated by rapamycin treatment and mimicked by HDAC6 inhibition. Together, the results of this study support the hypothesis that loss of TSC2 expression can alter microtubule organization and dynamics, which, in turn, deregulate cell division and potentially impair neuronal differentiation.

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

“…The short-hairpin (sh) RNA sequence targeting the expression of TSC2 corresponded to a construct from the MISSION (Sigma-Aldrich) library and has been described previously [ 33 , 34 ]. The lentiviral packaging, envelope, control and GFP expression plasmids (psPAX2, pMD2.G, non-hairpin-pLKO.1, scrambled-pLKO.1, and pWPT-GFP, respectively) were purchased from Addgene.…”

TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42

“…p Cortical bone thickness reduced slightly (n = 6). All experiments were repeated two times such as neural disorder [54]. In skeletal system, these small GTPases also play crucial roles in the differentiation, function, and survival of OCLs [12,32,33,[55][56][57][58].…”

Aging‐related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes

“…Endogenous peroxidases were blocked by incubation in 10% methanol-1% H 2 O 2 solution (15min) followed by 3% normal horse serum solution. Then the sections were incubated at 4ºC overnight with one of the primary antibodies against 4Rtau, 3Rtau, amino acids [14][15][16][17][18][19][20][21][22][23][24][25][26] (antibody 499), amino acids 229-233 (antibody 229), amino acids 394-398), specific phospho-tau Thr181, Ser199, Thr231, Ser262 and Ser422, double-phosphorylation sites Ser202-Thr205 (clone AT8), Ser396-404 (PHF1) and Thr212-Ser214 (tau-100), conformational tau modifications at amino acids 5-15 (Alz50) and amino acids 312-322 (MC-1), and tau truncated at aspartic acid 421 (tau-C3). Other sections were incubated with one of the following antibodies against glial fibrillary acidic protein (GFAP): P-GFAP Ser8, phosphorylated tuberin (P-tuberin Ser939), superoxide dismutase 2 (SOD2), aquaporine 4 (AQP4), phosphorylated p38 (p38-P Thr180-Tyr182), phosphorylated protein kinase A α/β (PKA-P α/β Thr197), glutamate transporter solute carrier family 1, member 2 (GLT-1/EAAT2), vimentin and YKL-40.…”